Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
toxicology
CRO
Charles River inks $510M deal to bring primate supply in-house
The service provider shared the news alongside details of a $60 million deal to buy the developer of a non-animal testing technology.
Nick Paul Taylor
Jan 14, 2026 10:45am
FDA issues plan to reduce primate testing for certain antibodies
Dec 2, 2025 11:25am
Incyte's $750M buyout rocked by pause on key trial, asset cull
Nov 19, 2024 4:12am
Danish CRO Scantox buys genotoxicity specialist Gentronix
Sep 10, 2024 7:44am
Scientists find largest protein ever in tiny toxic algae
Aug 12, 2024 12:02pm
AstraZeneca stops trials of asthma drug after seeing tox signal
Jun 21, 2023 9:10am